ID26996A - Pencegahan migren yang berulang - Google Patents

Pencegahan migren yang berulang

Info

Publication number
ID26996A
ID26996A IDW20010229A ID20010229A ID26996A ID 26996 A ID26996 A ID 26996A ID W20010229 A IDW20010229 A ID W20010229A ID 20010229 A ID20010229 A ID 20010229A ID 26996 A ID26996 A ID 26996A
Authority
ID
Indonesia
Prior art keywords
migrent
repeats
repeating
repeating migrent
migrent repeats
Prior art date
Application number
IDW20010229A
Other languages
English (en)
Inventor
Neville Colin Jackson
Stephen Uden
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ID26996A publication Critical patent/ID26996A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
IDW20010229A 1998-07-30 1999-06-14 Pencegahan migren yang berulang ID26996A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9816556.6A GB9816556D0 (en) 1998-07-30 1998-07-30 Therapy

Publications (1)

Publication Number Publication Date
ID26996A true ID26996A (id) 2001-02-22

Family

ID=10836395

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010229A ID26996A (id) 1998-07-30 1999-06-14 Pencegahan migren yang berulang

Country Status (36)

Country Link
EP (3) EP1466601A3 (id)
JP (1) JP3824863B2 (id)
KR (2) KR20030078876A (id)
CN (2) CN1522697A (id)
AP (1) AP1402A (id)
AT (1) ATE261304T1 (id)
AU (1) AU3952199A (id)
BG (1) BG65309B1 (id)
BR (1) BR9912588A (id)
CA (1) CA2338901C (id)
CZ (1) CZ2001357A3 (id)
DE (1) DE69915486T2 (id)
DK (1) DK1100499T3 (id)
EA (2) EA200201149A1 (id)
EE (1) EE04703B1 (id)
ES (1) ES2214027T3 (id)
GB (1) GB9816556D0 (id)
GE (2) GEP20043157B (id)
HK (1) HK1038198A1 (id)
HR (1) HRP20010079A2 (id)
HU (1) HUP0103424A3 (id)
ID (1) ID26996A (id)
IL (1) IL140169A0 (id)
IS (1) IS2253B (id)
NO (1) NO20010489L (id)
NZ (2) NZ508736A (id)
OA (1) OA11576A (id)
PL (1) PL194611B1 (id)
PT (1) PT1100499E (id)
SG (1) SG125910A1 (id)
SK (1) SK1182001A3 (id)
TR (1) TR200100314T2 (id)
TW (2) TWI248362B (id)
UA (1) UA76399C2 (id)
WO (1) WO2000006161A1 (id)
YU (2) YU6401A (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
GB9915231D0 (en) * 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
CN1176649C (zh) * 2002-10-16 2004-11-24 上海医药工业研究院 舒马普坦干粉吸入剂及其制备方法
AU2003303631B2 (en) * 2002-12-26 2008-05-29 Nuvo Pharmaceuticals (Ireland) Designated Activity Company Multilayer Dosage Forms Containing NSAIDs and Triptans
BRPI0409127A (pt) 2003-04-11 2006-03-28 Pfizer combinação farmacêutica compreendendo eletriptano e bicarbonato de sódio
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
FR2926721B1 (fr) * 2008-01-30 2011-07-22 Philippe Perovitch Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
EP2306998A4 (en) 2008-06-20 2011-06-15 Alphapharm Pty Ltd PHARMACEUTICAL FORMULATION
WO2011048496A1 (en) * 2009-10-23 2011-04-28 Fortuderm, Ltd. Triptans for the treatment of psoriasis
PT2838517T (pt) 2012-04-18 2018-01-04 Contera Pharma Aps Formulação farmacêutica disponível sob forma oral adequada para a melhoria da gestão dos distúrbios da mobilidade
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
CN104523709A (zh) * 2014-12-22 2015-04-22 青岛正大海尔制药有限公司 一种含有琥珀酸夫罗曲坦的复方缓释制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9190141U1 (id) * 1990-10-15 1993-07-15 Pfizer, Inc., New York, N.Y., Us
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5744482A (en) * 1994-10-05 1998-04-28 Eli Lilly And Company Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine
CA2259418A1 (en) * 1996-07-11 1998-01-22 Farmarc Nederland B.V. Pharmaceutical composition containing acid addition salt of basic drug
WO1999001135A1 (en) * 1997-07-03 1999-01-14 Pfizer Limited Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
US6514530B2 (en) * 1997-09-09 2003-02-04 Alza Corporation Dosage form comprising means for changing drug delivery shape

Also Published As

Publication number Publication date
KR100441732B1 (ko) 2004-07-27
BG65309B1 (bg) 2008-01-31
HUP0103424A2 (hu) 2002-02-28
SK1182001A3 (en) 2001-10-08
CN1522697A (zh) 2004-08-25
CN1309560A (zh) 2001-08-22
PT1100499E (pt) 2004-06-30
CA2338901C (en) 2008-02-19
BG105277A (en) 2001-11-30
EA004036B1 (ru) 2003-12-25
EP1466601A3 (en) 2005-04-13
JP3824863B2 (ja) 2006-09-20
PL345803A1 (en) 2002-01-02
YU20303A (sh) 2006-08-17
DE69915486T2 (de) 2005-03-03
EA200100089A1 (ru) 2001-08-27
WO2000006161A1 (en) 2000-02-10
SG125910A1 (en) 2006-10-30
IS5771A (is) 2000-12-15
EP1466601A2 (en) 2004-10-13
EP1100499A1 (en) 2001-05-23
KR20030078876A (ko) 2003-10-08
GEP20043157B (en) 2004-01-26
TW200300674A (en) 2003-06-16
IS2253B (is) 2007-06-15
GB9816556D0 (en) 1998-09-30
EA200201149A1 (ru) 2003-02-27
EE04703B1 (et) 2006-10-16
DE69915486D1 (de) 2004-04-15
TWI248362B (en) 2006-02-01
IL140169A0 (en) 2002-02-10
TW537893B (en) 2003-06-21
DK1100499T3 (da) 2004-06-14
NO20010489D0 (no) 2001-01-29
PL194611B1 (pl) 2007-06-29
YU6401A (sh) 2004-03-12
HK1038198A1 (en) 2002-03-08
UA76399C2 (en) 2006-08-15
AP1402A (en) 2005-04-29
HRP20010079A2 (en) 2002-02-28
CN1155379C (zh) 2004-06-30
EE200100061A (et) 2002-06-17
NZ508736A (en) 2003-09-26
NO20010489L (no) 2001-03-26
KR20010079582A (ko) 2001-08-22
ES2214027T3 (es) 2004-09-01
NZ527625A (en) 2005-01-28
OA11576A (en) 2004-07-01
HUP0103424A3 (en) 2003-05-28
AU3952199A (en) 2000-02-21
CZ2001357A3 (cs) 2001-10-17
EP1100499B1 (en) 2004-03-10
AP2001002056A0 (en) 2001-03-31
ATE261304T1 (de) 2004-03-15
GEP20063719B (en) 2006-01-10
CA2338901A1 (en) 2000-02-10
TR200100314T2 (tr) 2001-06-21
EP1435237A1 (en) 2004-07-07
JP2002521446A (ja) 2002-07-16
BR9912588A (pt) 2001-05-02

Similar Documents

Publication Publication Date Title
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
ID26509A (id) Komponen-komponen yang mengandung tetrahidrolipstatin
ID25720A (id) Pelarutan gas yang ditingkatkan
ATE252333T1 (de) Zahnbürste
ID26308A (id) Dihidropirimidin baru yang tersubstitusi secara 2-heterosiklik
DE69934002D1 (de) Zahnbürste
ID27289A (id) Penggunaan yang baru
DE69934771D1 (de) Zahnbürste
ID23216A (id) Peralatan penurun air-dalam
ID23728A (id) Peralatan pengunci berpegas
ID26996A (id) Pencegahan migren yang berulang
ID23429A (id) Komposisi-komposisi sertralina yang larut
DE29805323U1 (de) Zahnbürste
DE29807736U1 (de) Zahnbürste
ID29823A (id) Mengirimkan nomor yang diputar
DE29818314U1 (de) Generator
ID27593A (id) Tetrahidronaftilidinil-karboksamida yang mempunyai aktivitas anti-konvulsan
DE29808902U1 (de) Wagen
ID25932A (id) Campuran-campuran kapet yang mengandung organosilanapolisulfana
DE29900775U1 (de) Zahnbürste
DE29802497U1 (de) Kommutator
DE59907824D1 (de) Zahnbürste
DE59904307D1 (de) Siebgewebe
ID22325A (id) Casis mekanik
DE59901177D1 (de) Zahnbürste